XML 37 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Interim Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Operating activities    
Net income $ 1,923,243 $ 2,694,100
Adjustments to reconcile net income to net cash:    
Stock based compensation 129,024 77,315
Depreciation and amortization 462,448 180,560
Lease right of use financing 300,102
Bad debt expense 231,696
Decrease in deferred income tax (140,909)
Gain on involuntary disposition (net of tax) (1,714,261)
Changes in non-cash working capital items:    
Increase in accounts receivable (469,696) (634,517)
Decrease (Increase) in inventory 177,652 (603,378)
(Increase) Decrease in prepaid expenses (156,436) 55,280
Increase (Decrease) in accounts payable and accrued liabilities 869,286 (447,182)
Increase in taxes payable 729,353 133,130
Decrease in deferred revenue (14,251) (205,920)
Cash provided by (used in) operating activities 4,041,512 (464,873)
Investing activities    
Long term deposits 147
Investment (1,163,787) 13,414
Proceeds of insurance 2,407,325
Net purchase of property, equipment and leaseholds (1,397,196) (32,259)
Cash (used in) provided by investing activities (2,560,836) 2,388,480
Financing activities    
Repayment of short term line of credit (957,045)
Loan repayments (916,017) (150,895)
Loan proceeds received 1,100,000
Lease financing costs (300,102)
Dividends paid (1,476,357)
Partnership distributions (133,759)
Proceeds of issuance of common stock 335,010 36,360
Cash used in financing activities (2,348,270) (114,535)
Effect of exchange rate changes on cash 10,738 (127,036)
(Outflow) Inflow of cash (856,856) 1,682,036
Cash and cash equivalents, beginning 7,857,936 6,912,138
Cash, cash equivalents and restricted cash, ending 7,001,080 8,594,174
Supplemental disclosure of cash flow information:    
Income taxes paid 8,741 288,653
Interest paid 327,457 21,755
Common shares issued on conversion of convertible debt $ 500,000